Hydrochloric Acid → HCID 178525576, compound

HRID 70852Notes

Reaction equation

HRID 70852 reaction equation
C([O:3][C:4](=[O:30])[CH2:5][C@H:6]([NH:20][C:21](=[O:29])[CH2:22][CH2:23][C:24]1[NH:28][N:27]=[N:26][N:25]=1)[CH2:7][C:8]1[CH:13]=[CH:12][C:11]([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)=[CH:10][CH:9]=1)C.[OH-].[Na+].Cl>CCO>[C:11]1([C:14]2[CH:15]=[CH:16][CH:17]=[CH:18][CH:19]=2)[CH:12]=[CH:13][C:8]([CH2:7][C@@H:6]([NH:20][C:21](=[O:29])[CH2:22][CH2:23][C:24]2[NH:28][N:27]=[N:26][N:25]=2)[CH2:5][C:4]([OH:30])=[O:3])=[CH:9][CH:10]=1

Participants

5

Procedure

To a solution of (R)-4-biphenyl-4-yl-3-{3-[1-(2-cyano-ethyl)-1H-tetrazol-5-yl]-propionylamino}-butyric acid ethyl ester (137 mg, 0.297 mmol) in DCM (8 mL) at room temperature is added DBU (1.507 mL, 10.00 mmol) and the mixture is stirred at room temperature for 2 hours. The reaction is extracted with DCM. The combined organic layer is washed with saturated NH4Cl, brine and dried over anhydrous sodium sulfate, filtered and concentrated under reduced. The obtained residue is purified by flash chromatography (silica gel, 2% to 10% EtOH/DCM) to give (R)-4-bipheyl-4-yl-3-(3-1H-tetrazol-5-yl-propionylamino)-butyric acid ethyl ester (37 mg). To the obtained ester in EtOH (2 mL) at room temperature is added aqueous 1M NaOH (1 mL, 1.0 mmol) and the mixture is stirred at room temperature for 1 hour. To the reaction is added 1 mL of aqueous 1M HCl to pH=4, and the mixture is purified by reverse phase HPLC [30% to 60% acetonitrile-H2O (0.1% TFA)] to give (R)-4-bipheyl-4-yl-3-(3-1H-tetrazol-5-yl-propionylamino)-butyric acid. HPLC retention time=1.24 minutes (condition C); MS (m+1)=380; 1H NMR (400 MHz, DMSO-d6) δ ppm 2.37 (dd, J=6.7, 2.1 Hz, 2 H), 2.53 (t, J=7.6 Hz, 2 H), 2.69-2.82 (m, 2 H), 3.02 (t, J=7.7 Hz, 2 H), 4.17-4.29 (m, 1 H), 7.22 (d, J=8.3 Hz, 2 H), 7.34 (tt, J=7.3, 1.3 Hz, 1 H), 7.42-7.48 (m, 2 H), 7.57 (d, J=8.3 Hz, 2 H), 7.64 (dd, J=8.2, 1.1 Hz, 2 H), 8.00 (d, J=8.1 Hz, 1 H), 12.21 (br. s., 1 H), 15.92 (br. s., 1 H).

Workup

  1. customthe mixture is purified by reverse phase HPLC [30% to 60% acetonitrile-H2O (0.1% TFA)]

Sources & evidence

ORD record
ord-1f5a2e23581d4931b4128d590f486e9e
Source dataset
uspto-grants-2014_09
Patent number
US08822534B2

Reaction notes

Loading…